434 related articles for article (PubMed ID: 9798526)
1. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
[TBL] [Abstract][Full Text] [Related]
2. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
[TBL] [Abstract][Full Text] [Related]
3. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
[TBL] [Abstract][Full Text] [Related]
4. A novel heart failure model induced by sequential coronary artery occlusions and tachycardiac stress in awake pigs.
Shen YT; Lynch JJ; Shannon RP; Wiedmann RT
Am J Physiol; 1999 Jul; 277(1):H388-98. PubMed ID: 10409219
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
7. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
Richard V; Berdeaux A; Giudicelli JF
J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action.
Spinale FG; Iannini JP; Mukherjee R; Melton DM; de Gasparo M
J Card Fail; 1998 Dec; 4(4):325-32. PubMed ID: 9924854
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
[TBL] [Abstract][Full Text] [Related]
10. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
[TBL] [Abstract][Full Text] [Related]
12. Chronic therapy with an ET(A/B) receptor antagonist in conscious dogs during progression of congestive heart failure. Intracellular Ca(2+) regulation and nitric oxide mediated coronary relaxation.
Shen YT; Buie PS; Lynch JJ; Krause SM; Ma XL
Cardiovasc Res; 2000 Nov; 48(2):332-45. PubMed ID: 11054479
[TBL] [Abstract][Full Text] [Related]
13. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis.
Friedrich SP; Lorell BH; Rousseau MF; Hayashida W; Hess OM; Douglas PS; Gordon S; Keighley CS; Benedict C; Krayenbuehl HP
Circulation; 1994 Dec; 90(6):2761-71. PubMed ID: 7994819
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin pathway is involved in acute hemodynamic effects of enalaprilat in dogs with heart failure.
Barbe F; Su JB; Guyene TT; Crozatier B; Ménard J; Hittinger L
Am J Physiol; 1996 Jun; 270(6 Pt 2):H1985-92. PubMed ID: 8764248
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.
Suzuki J; Ohta H; Hanada K; Kawai N; Ikeda T; Nakao M; Ikemoto F; Nishikibe M
Hypertens Res; 2001 Jan; 24(1):65-74. PubMed ID: 11213032
[TBL] [Abstract][Full Text] [Related]
18. Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
Trippodo NC; Panchal BC; Fox M
J Pharmacol Exp Ther; 1995 Feb; 272(2):619-27. PubMed ID: 7853175
[TBL] [Abstract][Full Text] [Related]
19. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.
Su JB; Barbe F; Crozatier B; Campbell DJ; Hittinger L
J Cardiovasc Pharmacol; 1999 Nov; 34(5):700-10. PubMed ID: 10547087
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
